Johns Hopkins School of Medicine and nine other major peer institutions (The University of Pennsylvania, Cornell University, Columbia University, Brigham and Women’s Hospital, Massachusetts General Hospital, the University of Texas System, The Children’s Hospital of Philadelphia, Boston Children’s Hospital and The Regents of the University of California, on behalf of its San Francisco campus) have entered into an agreement with SANOFI for their third Innovations Awards Program. If proposed projects are selected they will receive a one-year award for $125,000 including indirect costs, which may be renewable for an additional year and/or successful Innovation Awards projects may receive additional ongoing sponsored awards beyond the Innovation Program. The Innovation Awards Agreement includes pre-negotiated terms of the Innovation Awards and additional follow-on Sponsored Awards with publication rights for the investigators and an IP option for SANOFI.
To be eligible for consideration, projects go through a two stage review; 1) first submit to Karen Falter at firstname.lastname@example.org a brief non-confidential pre-proposal by June 16, 2017 via email, and 2) SANOFI will select from the pre-proposals those projects that will be asked to prepare a more detailed confidential proposal by the end of July, under guidelines issued at that time. The requested detailed proposals will be due on August 28 and will be reviewed by a Joint Scientific Committee that includes a scientist from each of the participating institutions as well as from SANOFI. Selected awards are expected to be announced by November.
Please submit innovative translational research ideas that align with SANOFI's stated areas of interest in the attached announcement. Unfunded previous internal and external proposals and new proposal ideas can be used. Funding awards are only available for research conducted by researchers at this institution that does not involve a third-party collaborator. A third party-collaborator is considered (i) any researcher employed by an institution or entity that is not an institution/entity participating in the iAwards program, (ii) a funding source involving any organization or entity other than a state or federal government agency or (iii) a third party for which the confidential information, materials or methods or models described in the proposal involve third-party rights that may restrict the parties’ intellectual property rights as set forth in the Funding Award Agreement template.
If you have any questions contact Karen Falter email@example.com.
-Antony Rosen, Vice Dean for Research
Those interested in applying are encouraged to reach out to Kieren Marr, Vice Chair for Innovation in Healthcare Implementation